Inventor
BREDER CHRISTOPHER
US47 patents
⚠️ This page may combine multiple inventors who share the name “BREDER CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PURDUE PHARMA LP
40 patentsUS9060976B2Jun 23, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP72 citations99
US9044435B2Jun 2, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP55 citations99
US9040084B2May 26, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP38 citations99
US9034376B2May 19, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP48 citations99
US8999961B2Apr 7, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP41 citations99
US8871265B2Oct 28, 2014
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP51 citations99
US8609683B2Dec 17, 2013
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP85 citations99
US8529948B1Sep 10, 2013
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP80 citations99
US7842307B2Nov 30, 2010
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP221 citations99
US9387174B2Jul 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP26 citations98
US9387173B2Jul 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP27 citations98
US9308170B2Apr 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP24 citations98
US9308171B2Apr 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP25 citations98
US7914818B2Mar 29, 2011
Opioid agonist formulations with releasable and sequestered antagonist
PURDUE PHARMA LP46 citations98
US7141250B2Nov 28, 2006
Pharmaceutical formulation containing bittering agent
PURDUE PHARMA LP224 citations98
US10206881B2Feb 19, 2019
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP7 citations93
US10076497B2Sep 18, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US10071057B2Sep 11, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US10064824B2Sep 4, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US9877924B2Jan 30, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP4 citations93
US9872836B2Jan 23, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP8 citations93
US9757341B2Sep 12, 2017
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP4 citations93
US9693961B2Jul 4, 2017
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP7 citations93
US9517207B2Dec 13, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US9101668B2Aug 11, 2015
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP12 citations93
US10537526B2Jan 21, 2020
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations84
US10500160B2Dec 10, 2019
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations84
US10130586B2Nov 20, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP2 citations84
US10064825B2Sep 4, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP3 citations84
US8815287B2Aug 26, 2014
Opiod agonist formulations with releasable and sequestered antagonist
PURDUE PHARMA LP8 citations84
US9968559B2May 15, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations74
US9867783B2Jan 16, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations74
US9867784B2Jan 16, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations74
US9861583B2Jan 9, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations74
US9861582B2Jan 9, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP1 citations74
US11135171B2Oct 5, 2021
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP0 citations73
US8758825B2Jun 24, 2014
Sequestered antagonist formulations
PURDUE PHARMA LP5 citations73
US9949930B2Apr 24, 2018
Opioid agonist formulations with releasable and sequestered antagonist
PURDUE PHARMA LP0 citations52
US9808453B2Nov 7, 2017
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP0 citations52
US9561225B2Feb 7, 2017
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP0 citations52
BREDER CHRISTOPHER
3 patentsUS8465774B2Jun 18, 2013
Sequestered antagonist formulations
BREDER CHRISTOPHER52 citations97
US8518443B2Aug 27, 2013
Opioid agonist formulations with releasable and sequestered antagonist
BREDER CHRISTOPHER22 citations92
US8231901B2Jul 31, 2012
Opioid agonist formulations with releasable and sequestered antagonist
BREDER CHRISTOPHER20 citations92